Christel Müller

Emergence of clonal cytogenetic abnormalities in Ph−cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority

Thomas G.P. Bumm, Christel Müller, Haifa Kathrin Al‐Ali et al. · Blood · 2003 · 221 citations

High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib

Haifa Kathrin Al‐Ali, Michael C. Heinrich, Thoralf Lange et al. · The Hematology Journal · 2004 · 109 citations

Hematological Malignancy, Oncology, Engineering +11

Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes

Christina Ganster, Catharina Müller‐Thomas, Claudia Haferlach et al. · Genes Chromosomes and Cancer · 2019 · 13 citations · Full text

No evidence for persistence of BCR-ABL–positive cells in patients in molecular remission after conventional allogeneic transplantation for chronic myeloid leukemia

Michael W. Deininger, Tornalf Lehmann, Rainer Krahl et al. · Blood · 2000 · 11 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Transplantation +10